514 related articles for article (PubMed ID: 25863795)
21. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
[TBL] [Abstract][Full Text] [Related]
22. Relationship between cone-beam CT technique and diagnostic usefulness in patients undergoing embolotherapy for hepatocellular carcinoma.
Gutierrez D; Gurajala RK; Kapoor B; Setser R; Karuppasamy K
Clin Radiol; 2017 Nov; 72(11):993.e1-993.e6. PubMed ID: 28705329
[TBL] [Abstract][Full Text] [Related]
23. Automatic bone removal for 3D TACE planning with C-arm CBCT: Evaluation of technical feasibility.
Wang Z; Hansis E; Chen R; Duran R; Chapiro J; Sheu YR; Kobeiter H; Grass M; Geschwind JF; Lin M
Minim Invasive Ther Allied Technol; 2016; 25(3):162-70. PubMed ID: 26923140
[TBL] [Abstract][Full Text] [Related]
24. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
25. Comparing the detectability of hepatocellular carcinoma by C-arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging.
Loffroy R; Lin M; Rao P; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Geschwind JF
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):97-104. PubMed ID: 21328023
[TBL] [Abstract][Full Text] [Related]
26. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
27. Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization.
Tacher V; Lin M; Bhagat N; Abi Jaoudeh N; Radaelli A; Noordhoek N; Carelsen B; Wood BJ; Geschwind JF
J Vis Exp; 2013 Dec; (82):50795. PubMed ID: 24326874
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
[TBL] [Abstract][Full Text] [Related]
29. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
[TBL] [Abstract][Full Text] [Related]
30. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
31. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
[TBL] [Abstract][Full Text] [Related]
32. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization.
Wang X; Yarmohammadi H; Cao G; Ji X; Hu J; Yarmohammadi H; Chen H; Zhu X; Yang R; Solomon SB
J Cancer Res Ther; 2017; 13(1):38-43. PubMed ID: 28508831
[TBL] [Abstract][Full Text] [Related]
33. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
Park VY; Choi JY; Chung YE; Kim H; Park MS; Lim JS; Kim KW; Kim MJ
Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
[TBL] [Abstract][Full Text] [Related]
34. Cone-Beam Computed Tomography (CBCT) Hepatic Arteriography in Chemoembolization for Hepatocellular Carcinoma: Performance Depicting Tumors and Tumor Feeders.
Lee IJ; Chung JW; Yin YH; Kim HC; Kim YI; Jae HJ; Park JH
Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1218-30. PubMed ID: 25720741
[TBL] [Abstract][Full Text] [Related]
35. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Image Quality and Diagnostic Performance of Cone-Beam CT during Drug-Eluting Embolic Transarterial Chemoembolization and Multidetector CT in the Detection of Hepatocellular Carcinoma.
Lucatelli P; Argirò R; Ginanni Corradini S; Saba L; Cirelli C; Fanelli F; Ricci C; Levi Sandri GB; Catalano C; Bezzi M
J Vasc Interv Radiol; 2017 Jul; 28(7):978-986. PubMed ID: 28495451
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of MDCT angiography for determination of tumor-feeding vessels in chemoembolization of hepatocellular carcinoma.
Kim I; Kim DJ; Kim KA; Yoon SW; Lee JT
J Comput Assist Tomogr; 2014; 38(5):742-6. PubMed ID: 24834885
[TBL] [Abstract][Full Text] [Related]
38. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
[TBL] [Abstract][Full Text] [Related]
39. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
40. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
